Your browser doesn't support javascript.
loading
Genetic regulators of sputum mucin concentration and their associations with COPD phenotypes.
Van Buren, Eric; Radicioni, Giorgia; Lester, Sarah; O'Neal, Wanda K; Dang, Hong; Kasela, Silva; Garudadri, Suresh; Curtis, Jeffrey L; Han, MeiLan K; Krishnan, Jerry A; Wan, Emily S; Silverman, Edwin K; Hastie, Annette; Ortega, Victor E; Lappalainen, Tuuli; Nawijn, Martijn C; Berge, Maarten van den; Christenson, Stephanie A; Li, Yun; Cho, Michael H; Kesimer, Mehmet; Kelada, Samir N P.
Afiliação
  • Van Buren E; Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, United States of America.
  • Radicioni G; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
  • Lester S; Marsico Lung Institute, University of North Carolina, Chapel Hill, North Carolina, United States of America.
  • O'Neal WK; Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, United States of America.
  • Dang H; Marsico Lung Institute, University of North Carolina, Chapel Hill, North Carolina, United States of America.
  • Kasela S; Marsico Lung Institute, University of North Carolina, Chapel Hill, North Carolina, United States of America.
  • Garudadri S; New York Genome Center, New York, New York, United States of America.
  • Curtis JL; Department of Systems Biology, Columbia University, New York, New York, United States of America.
  • Han MK; Division of Pulmonary, Critical Care, Allergy, & Sleep Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
  • Krishnan JA; Pulmonary & Critical Care Medicine Division, University of Michigan, Ann Arbor, Michigan, United States of America.
  • Wan ES; Medical Service, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, United States of America.
  • Silverman EK; Pulmonary & Critical Care Medicine Division, University of Michigan, Ann Arbor, Michigan, United States of America.
  • Hastie A; Breathe Chicago Center, University of Illinois, Chicago, Illinois, United States of America.
  • Ortega VE; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Lappalainen T; VA Boston Healthcare System, Jamaica Plain, Massachusetts, United States of America.
  • Nawijn MC; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Berge MVD; Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America.
  • Christenson SA; Department of Internal Medicine, Division of Respiratory Medicine, Mayo Clinic, Scottsdale, Arizona, United States of America.
  • Li Y; New York Genome Center, New York, New York, United States of America.
  • Cho MH; Department of Systems Biology, Columbia University, New York, New York, United States of America.
  • Kesimer M; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Kelada SNP; Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, Groningen, the Netherlands.
PLoS Genet ; 19(6): e1010445, 2023 06.
Article em En | MEDLINE | ID: mdl-37352370
ABSTRACT
Hyper-secretion and/or hyper-concentration of mucus is a defining feature of multiple obstructive lung diseases, including chronic obstructive pulmonary disease (COPD). Mucus itself is composed of a mixture of water, ions, salt and proteins, of which the gel-forming mucins, MUC5AC and MUC5B, are the most abundant. Recent studies have linked the concentrations of these proteins in sputum to COPD phenotypes, including chronic bronchitis (CB) and acute exacerbations (AE). We sought to determine whether common genetic variants influence sputum mucin concentrations and whether these variants are also associated with COPD phenotypes, specifically CB and AE. We performed a GWAS to identify quantitative trait loci for sputum mucin protein concentration (pQTL) in the Sub-Populations and InteRmediate Outcome Measures in COPD Study (SPIROMICS, n = 708 for total mucin, n = 215 for MUC5AC, MUC5B). Subsequently, we tested for associations of mucin pQTL with CB and AE using regression modeling (n = 822-1300). Replication analysis was conducted using data from COPDGene (n = 5740) and by examining results from the UK Biobank. We identified one genome-wide significant pQTL for MUC5AC (rs75401036) and two for MUC5B (rs140324259, rs10001928). The strongest association for MUC5B, with rs140324259 on chromosome 11, explained 14% of variation in sputum MUC5B. Despite being associated with lower MUC5B, the C allele of rs140324259 conferred increased risk of CB (odds ratio (OR) = 1.42; 95% confidence interval (CI) 1.10-1.80) as well as AE ascertained over three years of follow up (OR = 1.41; 95% CI 1.02-1.94). Associations between rs140324259 and CB or AE did not replicate in COPDGene. However, in the UK Biobank, rs140324259 was associated with phenotypes that define CB, namely chronic mucus production and cough, again with the C allele conferring increased risk. We conclude that sputum MUC5AC and MUC5B concentrations are associated with common genetic variants, and the top locus for MUC5B may influence COPD phenotypes, in particular CB.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Mucinas Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Mucinas Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article